▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #847 by analyst upside · 2026-11-08
TTRX
Turn Therapeutics Inc.
Healthcare · Market Cap $288M · P/E 0x
ANALYST PRICE TARGET
+163.7%
implied upside to consensus target
Current Price $9.48
Consensus Target $25.0
Bull Target $26.0
Bear Target $24.0
Analysts Covering 2
ANALYST CONSENSUS - BUY
Strong Buy
0
Buy
2
Hold
0
Sell
0
52-Week Low $2.57
52-Week High $16.45
YTD Return +102.1%
FUNDAMENTALS
Market Cap $288M
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-0.29
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) N/A
Profit Margin N/A
52-WEEK RANGE
52-Week Low $2.57
52-Week High $16.45
Current Price $9.48
Bear Target $24.0
Bull Target $26.0
● Now $9.48 ● Target $25.0
TRADING DATA
Avg Volume 111K
YTD Return +102.1%
Analyst Count 2
Consensus Buy
Upside to Target +163.7%
Last Updated 2026-11-08

ANALYST SUMMARY

Turn Therapeutics Inc. (TTRX) is currently trading at $9.48 with a Wall Street consensus price target of $25.0, implying potential upside of 163.7% over the next 12 months. 2 analysts currently cover TTRX, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $26.0, while the most cautious has a target of $24.0.

TTRX operates in the Healthcare sector with a market capitalisation of $288M. The stock is up 102.1% year-to-date and is currently trading near the lower end of its 52-week range of $2.57 – $16.45.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for TTRX, with each firm's 90-day track record across all stocks we track. See full firm rankings →

WBB Securities ↑ Upgrade
Sell → Hold 2026-10-23 Building track record
LUCID CAPITAL MARKETS ● Initiated
Buy 2026-09-24 40% win rate (5 calls)
WBB Securities ↓ Downgrade
Hold → Sell 2026-09-14 Building track record
D. Boral Capital - Reiterated
Buy → Buy 2026-03-24 32% win rate (25 calls)
D. Boral Capital - Reiterated
Buy → Buy 2026-01-20 32% win rate (25 calls)
D. Boral Capital ● Initiated
Buy 2025-12-29 32% win rate (25 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
61
out of 100
Coverage depth
8/30
Consensus clarity
26/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →